Firefly Neuroscience, Inc. (NASDAQ:AIFF) Short Interest Update

Firefly Neuroscience, Inc. (NASDAQ:AIFF) saw a significant decline in short interest in October. As of October 15th, there was short interest totaling 491,300 shares, a decline of 44.4% from the September 30th total of 884,200 shares. Currently, 6.2% of the shares of the stock are sold short. Based on an average daily volume of 1,670,000 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily volume of 1,670,000 shares, the days-to-cover ratio is currently 0.3 days. Currently, 6.2% of the shares of the stock are sold short.

Firefly Neuroscience Trading Down 2.1%

NASDAQ:AIFF opened at $1.88 on Friday. Firefly Neuroscience has a 1 year low of $1.85 and a 1 year high of $17.20. The firm has a 50 day moving average of $2.66 and a 200-day moving average of $2.91. The stock has a market capitalization of $25.29 million, a P/E ratio of -0.75 and a beta of 2.11.

Firefly Neuroscience (NASDAQ:AIFF) last posted its quarterly earnings data on Wednesday, August 13th. The company reported ($0.14) earnings per share for the quarter. Firefly Neuroscience had a negative return on equity of 464.02% and a negative net margin of 5,335.75%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Insider Activity

In other news, major shareholder Windsor Private Capital Lp sold 78,031 shares of Firefly Neuroscience stock in a transaction that occurred on Wednesday, October 22nd. The shares were sold at an average price of $2.07, for a total value of $161,524.17. Following the completion of the transaction, the insider owned 1,236,773 shares in the company, valued at approximately $2,560,120.11. The trade was a 5.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have sold a total of 400,000 shares of company stock valued at $1,015,775 in the last three months. Insiders own 6.44% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Firefly Neuroscience stock. Geode Capital Management LLC increased its stake in Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 120,604 shares of the company’s stock after purchasing an additional 58,067 shares during the period. Geode Capital Management LLC owned 0.94% of Firefly Neuroscience worth $341,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 4.96% of the company’s stock.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.